2m 2m 2m 2m 2m 2m 2m
TARSUS PHARMA (TARS)
NASDAQ
$66.21+$2.65 (+4.17%)
Price as of Jun 23, 2026 5:03 PM EDT- $2.7BMarket Cap
- 56.55%1-Year Change
- BiotechnologyIndustry
TARSUS PHARMA (TARS)
$66.21+$2.65 (+4.17%)
Earnings Score
Valuation | TARS | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | TARS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -5.06% | ||
12-Month Momentum | 59.38% | ||
3-Month Risk Adjusted Momentum | -26.30% | ||
12-Month Risk Adjusted Momentum | 138.39% |
True Yield
Valuation | TARS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.04% | ||
Net Debt Paydown Yield | -0.006% |
Financial Health Score
Valuation | TARS | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |